hydroxychloroquine has been researched along with Pulmonary Eosinophilia in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, Y | 1 |
| Muro, Y | 1 |
| Murase, C | 1 |
| Takeichi, T | 1 |
| Kono, M | 1 |
| Adachi, R | 1 |
| Takahashi, K | 1 |
| Akiyama, M | 1 |
1 other study available for hydroxychloroquine and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Betamethasone; Chilblains; Drug Therapy, Comb | 2019 |